Pennside Partners, Ltd. is a leading business development consulting firm serving the pharmaceutical, biotechnology, and medical device sectors worldwide.
This year Pennside Partners celebrates over 25 years of being a trusted partner within the pharma and biotech industries.
At Pennside, we have gained our client’s trust by consistently delivering high-quality, actionable business insight and competitive intelligence. Our mission is to help our pharma and biotech clients rapidly formulate winning strategies and tactics by providing the industry’s most accurate business intelligence and market insight. With headquarters in both the United States and Switzerland, we are able to quickly and thoroughly respond to the unique needs of each client worldwide.
What Pennside Partners, Ltd. Offers
Pennside Partners, Ltd. provides of the following services:
- Competitive benchmarking
- Therapeutic category monitoring
- Developmental pipeline analysis
- Brand strategy support
- New commercial models
- Pricing & reimbursement
- Technology due diligence
- War games and strategy
- Manufacturing cost analysis
- Clinical/ regulatory strategy
- OTC drugs and Rx switch
- Orphan / rare drug launch
Pennside Partners, Ltd. can provide insight to these therapeutic categories of interest:
- Orphan / rare disease
- Endocrinology/ Diabetes
- Rheumatology & bone health
- Women’s health
What is in store for Pennside Partners, Ltd.
In the weeks and months ahead we plan to devote considerable energy to addressing key biotechnology and pharmaceutical industry topics of interest, including:
- Prelaunch and launch planning
- Launch analogs
- Business development
- Brand strategy
- Competitive intelligence (CI) and monitoring
- Pipeline analysis
- Disease landscape
- Licensing and acquisition
Meet Pennside’s Team
Michael A. Rhoads, President and Co- founder
Mike has 25 years of experience as a consultant to the global pharmaceutical industry. He has managed over 300 competitive clinical benchmarking assignments since 1990. Under his supervision, the Pennside medical staff has completed a variety of strategic and tactical assessments covering all major therapeutic categories. As Director of the Clinical Strategies Group within Pennside, he personally directed multiple clinical CI programs in various therapeutic categories. Mike is one of the earliest participants in the Society of Competitive Intelligence Professionals (SCIP), and an acknowledged expert in the field of competitive clinical intelligence. He has delivered numerous keynote addresses at SCIP annual meetings and was selected to conduct two specific educational workshops for the drug industry in recent years.
Mike earned his MBA from the Wharton School of Business at the University of Pennsylvania and a B.A. from Colgate University.
Thomas J. Penrice, Vice President and Co- founder of Pennside Partners, Ltd.
Tom has over 25 years of experience in the pharmaceutical industry. As a pharmaceutical industry consultant since 1986, he has conducted and managed hundreds of projects in most major disease states and numerous drug delivery technologies.
Tom earned his MBA from the Advanced Management Program at Michigan State University and a B.S. in chemistry from Marquette University.
Anthony Arleth, Managing Director US
Tony has over 20 years of experience in the pharmaceutical industry. He spent 21 years at GlaxoSmithKline, with extensive experience in business opportunity analysis. He began his career as a bench scientist and is a trained biochemist / molecular pharmacologist. He brings a wide range of industry knowledge to Pennside, with specialization in the Cardiovascular, Oncology, and Pharmacogenetic areas.
Tony earned his undergraduate degree from Villanova University and conducted graduate work at the University of Pennsylvania and Villanova University
Eric Vaichunas, M.D., MHSA, Medical Director
Eric has over four years of clinical experience in general medicine. Over the course of his experience, he was involved in various aspects of the internal medicine field with several key opinion leaders at Michael Reese Hospital, Chicago, IL, St. Vincent’s Hospital, New York, NY; and Mount Sinai School of Medicine, New York, NY.
Eric earned his M.D. from St. Matthew’s School of Medicine, his M.S. in Health Service Administration from St. Joseph’s College of Maine, and his B.S. in Biomedical Science from Hahnemann University. Eric completed a year of graduate work in Biomedical Science at the Philadelphia College of Osteopathic Medicine.
To learn more about the advantages of our leading strategic consulting services contact our US or EU offices:
US: +1 610 372 7000
UK: +44 20 3695 7639
Switzerland: +41 79 372 7070